FAQ
GMP Manufacturing
FAQ
Article
Dual source manufacturing strategy: One program. Two regions. One integrated team.
Jun 24, 2026
FAQ
Q: What is Rezon Bio’s batch success rate and regulatory audit track record?
Jun 23, 2026
FAQ
Q: How efficiently can Rezon Bio take an NBE from gene to IND?
Jun 17, 2026
Article
Interview with Adriana Kiędzierska-Mencfeld: Turning Biologic Innovation into Commercial Reality
Jun 15, 2026
Article
Strengthening Europe’s biologics capabilities: FENG grant agreement signed with PARP
Jun 1, 2026
FAQ
Q: Is Rezon Bio a price competitive option for European biologics manufacturing?
May 28, 2026
Webinar
Webinar: Integrated biologics development and manufacturing in Europe: Enabling seamless transition from early phase to commercial supply
May 21, 2026
Podcast
Podcast: The Hidden Challenges in Biologics Development – Insights from Adriana Kiedzierska-Mencfeld
Apr 21, 2026
Article
Closer to Industry: Interview with Adriana Kiędzierska-Mencfeld, CEO of Rezon Bio
Feb 19, 2026
Press Release
FDA Approval granted for Commercial Manufacturing at Rezon Bio’s Warsaw-Duchnice Facility
Feb 18, 2026
Article
Meeting the Evolving Challenges of a Maturing Global Biologics Market
Dec 8, 2025No posts found.
Loading…